Ads
related to: hemophilia medicine treatment drugs names and pictures of pills
Search results
Results from the WOW.Com Content Network
Molar mass. 145 639.02 g·mol −1. Emicizumab, sold under the brand name Hemlibra, is a humanized bispecific monoclonal antibody for the treatment of haemophilia A, developed by Genentech and Chugai (both organizations are subsidiaries of Hoffmann-La Roche). [4] A Phase I clinical trial found that it was well tolerated by healthy subjects.
Formula. C6462H10004N1712O2046S46. Molar mass. 145 887.81 g·mol −1. Concizumab, sold under the brand name Alhemo, is a monoclonal antibody used for the treatment of hemophilia B. [5] It is an anti- tissue factor pathway inhibitor. [5] Concizumab was approved for medical use in Canada in March 2023. [4][7]
Prothrombin complex concentrate (PCC), also known as factor IX complex, sold under the brand name Kcentra among others, is a combination medication made up of blood clotting factors II, IX, and X [9] (3-factor PCC) or, when also containing factor VII as does Kcentra, 4-factor PCC. [10] It is used to treat and prevent bleeding in hemophilia B if ...
Hympavzi is the first and only anti-tissue factor pathway inhibitor (anti-TFPI) approved in the U.S. for hemophilia A or B and the first hemophilia medicine approved in the U.S. to be administered via
Factor VIII (medication) Factor VIII is a medication used to treat and prevent bleeding in people with hemophilia A and other causes of low factor VIII. [10][11] Certain preparations may also be used in those with von Willebrand's disease. [11] It is given by slow injection into a vein.
A novel medication for hemophilia B has just been approved by the Food and Drug Administration. The treatment is a form of gene therapy, intended to replace a dysfunctional gene that leaves people ...
Biogen Idec (BIIB) and Swedish Orphan Biovitrum said a potential hemophilia B treatment has met safety goals in an early-stage study. The study involved 14 previously treated patients, and the ...
Etranacogene dezaparvovec, sold under the brand name Hemgenix is a gene therapy used for the treatment of hemophilia B. [ 5 ][ 6 ][ 7 ] Etranacogene dezaparvovec is an adeno-associated virus vector-based gene therapy which consists of a viral vector carrying a gene for clotting Factor IX. [ 7 ] The gene is expressed in the liver to produce ...
Ads
related to: hemophilia medicine treatment drugs names and pictures of pills